Recombinant IFN - treatment in patients with invasive Candida and/or Aspergillus infections partially restored immune function , as characterized by an increased HLA-DR expression in those patients with a baseline expression below @ % , and an enhanced capacity of leukocytes from treated patients to produce proinflammatory cytokines involved in antifungal defence .